ST. LOUIS, March 13, 2018 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the Oppenheimer28th Annual Healthcare Conference, to be held March 20-21, 2018, at The Westin New York Grand Central in New York City.
Centene is scheduled to present on Wednesday,
A webcast replay of the presentation will be available afterwards via the Company's website at www.centene.com under the Investors section.
About Centene CorporationCentene Corporation, a Fortune 100 company, is a diversified, multinational healthcare enterprise that provides programs and services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long Term Care (LTC), in addition to other state-sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as "Part D"), as well as programs with the U.S. Department of Defense and U.S. Department of Veterans Affairs. The Company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, care management software, correctional systems healthcare, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.
Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://www.centene.com/investors.
View original content:http://www.prnewswire.com/news-releases/centene-to-present-at-oppenheimer-28th-annual-healthcare-conference-300613409.html
SOURCE Centene Corporation
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All